Epigral targets 20% annual growth, expects to more than double revenue by FY28

Epigral Q3 result: PAT more than doubles to Rs 103.63 cr

Multibagger Stock: Epigral yields 120% return in a year, 430% in over 3 years

Epigral consolidated net profit rises 114.00% in the September 2024 quarter

Board of Epigral approves doubling of capacity at Dahej

Epigral Q2 FY25 PAT up 111% to Rs. 81 Cr

Eprigral raises Rs. 333 crore via QIP issue

Chemical manufacturer Epigral Ltd raises Rs 333 crore via QIP issue

Epigral commissions 35,000 TPA CPVC compound manufacturing plant

Building a Resilient Brand in the Chemical Industry: The Epigral Story

Mr. Maulik Patel, CMD, Epigral, interview with ICN on FY2024 performance and growth prospects

Epigral Q4 FY24 QoQ PAT up 55% at Rs. 77 Cr

Epigral jumps after Q4 PAT rises 57% QoQ to Rs 77 cr

Epigral Ltd recommends final dividend of Rs. 5

Epigral Ltd Q4 FY24 consolidated PAT jumps QoQ to Rs. 77.27 crores

Epigral expands its CPVC resin capacity to 75,000 TPA

Epigral commissioned and expanded its CPVC resin capacity by 1.5 times to 75,000 TPA

Epigral commissions 45,000 TPA capacity of CPVC resin plant at Dahej

Explore our solutions – Connect with Epigral

Important Links

Quick Links

Contact

Monday-Saturday: 08am-9pm
+91 79 29709600

Want to email us instead?
in**@ep*****.com

At Epigral, we are at the forefront of India’s chemical industry, bringing solutions by providing essential derivatives and specialty chemicals.

© 2023 Copyrights Epigral Limited. All Rights Reserved.